© 1994 by European Society of Cardiology
Copyright © 1994, European Society of Cardiology
Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant
Astra Hässle AB, Preclinical Research and Development, Cardiovascular Pharmacology, S-431 83 Mölndal, Sweden: C Abrahamsson, M Palmer, B Ljung, G Duker, C Bäärnhielm, L Carlsson; AB Astra, Safety Assessment, Södertälje, Sweden: B Danielsson.
Correspondence to Dr Abrahamsson.
Objectives: The aim was to test the hypothesis that the recently reported embryotoxic effect of class III antiarrhythmic agents may be a result of electrophysiological disturbances induced by these agents. Methods: Comparative studies of drug effects in the adult and fetal rat were performed using three experimental models: (1) effects of almokalant upon pregnancy and fetal mortality in rats given daily doses of 0, 10, 50, 100, or 400 (µmol·kg–1 orally in the diet on days 6-15 of pregnancy; (2) effects of d-sotalol (1-1000 µM), almokalant (0.1-100 µM) and dofetilide (0.01-10 µM) on the adult and fetal cardiac action potential in vitro; (3) voltage clamp recordings in single fetal and adult ventricular myocytes superfused with almokalant (0.5 µM). Results: In the groups of rats treated with 100 and 400 µmol·kg–1, respectively, the body weight gain was decreased from day 12 of gestation, and there were no viable fetuses at termination of pregnancy. In atrial as well as ventricular tissue, the class III agents induced a concentration dependent prolongation of the fetal action potential duration, accompanied by a reduction in heart rate and eventually the appearance of rhythm abnormalities and/or early afterdepolarisations. The adult action potential duration remained unaffected. An almokalant sensitive current (probably the delayed rectifier, IK) could be evoked both in the fetal and in the adult ventricular cells. Conclusions: Class III antiarrhythmic agents were shown to induce fetal mortality and rhythm abnormalities in the rat heart. Although they do not prove a causal relationship between these effects, our observations may have implications for the clinical use of class III antiarrhythmic agents in women of childbearing potential.
Cardiovascular Research 1994;28:337-344
KEYWORDS d-sotalol; almokalant; dofetilide; action potential; voltage clamp; adult and fetal heart; embryotoxicity; early afterdepolarisation
We wish to acknowledge Dr Olle Almgren for his critical comments.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. B. Clark, M. E. Mangoni, A. Lueger, B. Couette, J. Nargeot, and W. R. Giles A rapidly activating delayed rectifier K+ current regulates pacemaker activity in adult mouse sinoatrial node cells Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1757 - H1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.N. M. N. Obreztchikova, E.A. E. A. Sosunov, A. Plotnikov, E.P. E. P. Anyukhovsky, R. Z. Gainullin, P. Danilo Jr., Z.-H. Yeom, R. B. Robinson, and M. R. Rosen Developmental changes in IKr and IKs contribute to age-related expression of dofetilide effects on repolarization and proarrhythmia Cardiovasc Res, August 1, 2003; 59(2): 339 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Carlsson Drug-induced torsade de pointes: the perspectives of industry Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K114 - K120. [Abstract] [PDF]
|
|
|
|
|
|
T.G Hammond, L Carlsson, A.S Davis, W.G Lynch, I MacKenzie, W.S Redfern, A.T Sullivan, and A.J Camm Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey Cardiovasc Res, March 1, 2001; 49(4): 741 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Pond, B. K. Scheve, A. T. Benedict, K. Petrecca, D. R. Van Wagoner, A. Shrier, and J. M. Nerbonne Expression of Distinct ERG Proteins in Rat, Mouse, and Human Heart. RELATION TO FUNCTIONAL IKr CHANNELS J. Biol. Chem., February 25, 2000; 275(8): 5997 - 6006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Priori, J. Barhanin, R. N. W. Hauer, W. Haverkamp, H. J. Jongsma, A. G. Kleber, W. J. McKenna, D. M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and Molecular Basis of Cardiac Arrhythmias: Impact on Clinical Management Part III Circulation, February 9, 1999; 99(5): 674 - 681. [Full Text] [PDF]
|
|
|
|
 |
|
 S.G. Priori, J. Barhanin, R.N.W. Hauer, W. Haverkamp, H.J. Jongsma, A.G. Kleber, W.J. McKenna, D.M. Roden, Y. Rudy, K. Schwartz, et al. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management Eur. Heart J., February 1, 1999; 20(3): 174 - 195. [PDF]
|
|
|
|
 |
|
 R. S. Wymore, G. A. Gintant, R. T. Wymore, J. E. Dixon, D. McKinnon, and I. S. Cohen Tissue and Species Distribution of mRNA for the IKr-like K+ Channel, erg Circ. Res., February 1, 1997; 80(2): 261 - 268. [Abstract] [Full Text]
|
|
|
|
|
|
W. Guo, K. Kamiya, and J. Toyama Differential effects of chronic membrane depolarization on the K+ channel activities in cultured rat ventricular cells Cardiovasc Res, January 1, 1997; 33(1): 139 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, Z.-P. Feng, C. S. Kondo, R. S. Sheldon, and H. J. Duff Developmental Changes in the Delayed Rectifier K+ Channels in Mouse Heart Circ. Res., July 1, 1996; 79(1): 79 - 85. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yang, S. Kupershmidt, and D. M. Roden Anti-minK Antisense Decreases the Amplitude of the Rapidly Activating Cardiac Delayed Rectifier K+ Current Circ. Res., December 1, 1995; 77(6): 1246 - 1253. [Abstract] [Full Text]
|
|